Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Difficulties, disconnections, and disarray

Journal of Evaluation in Clinical Practice

Volumn 23, Issue 4, 2017, Pages 719-724

  Perry, Lin ^a   James, Steven ^b   Gallagher, Robyn ^c   Dunbabin, Janet ^d   Steinbeck, Katharine ^e   Lowe, Julia ^f  

^a SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

delivery of health care; diabetes mellitus type 1; insulin infusion systems; patient care

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ARTICLE; ATTITUDE ASSESSMENT; AUSTRALIA; CONTINUOUS INFUSION; DIFFICULTY; DISARRAY; DISCONNECTION; ETHNOGRAPHIC RESEARCH; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH SERVICE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; PERSONNEL SHORTAGE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SOCIAL SUPPORT; TELEPHONE; THEMATIC ANALYSIS; CULTURAL ANTHROPOLOGY; EQUIPMENT DESIGN; HEALTH PERSONNEL ATTITUDE; INSULIN INFUSION; NEW SOUTH WALES; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT EDUCATION; PROCEDURES; SELF CARE; UTILIZATION;

ANTHROPOLOGY, CULTURAL; ATTITUDE OF HEALTH PERSONNEL; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; NEW SOUTH WALES; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; QUALITATIVE RESEARCH; SELF CARE;

EID: 85013477735     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12703     Document Type: Article

References (33)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
2. McMahon S, Airey F, Marangou D, et al. Insulin pump therapy in children and adolescents: Improvements in key parameters of diabetes management including quality of life. Diabet Med. 2005;22:92–96.
3. Misso M, Egberts K, Page M. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. CD005103. Cochrane Database Syst Rev. 2010.
4. Yeh H, Brown T, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analyses. Ann Intern Med. 2012;157(5):336–347.
5. Alsaleh F, Smith F, Keady S, et al. Insulin pumps: from inception to the present and toward the future. J Clin Pharm Ther. 2010;35:127–138.
6. Beck R, Tamborlane W, Bergenstal R, et al. The T1D exchange clinic registry. J Clin Endocrinol Metab. 2012;97(12):4383–4389.
7. Australian Institute of Health and Welfare, Insulin pump use in Australia. Diabetes series no.18; cat. No. CVD 58. Australian Government: Canberra, 2012.
8. Selam J. CSII in Europe: where are we, where are we going? An analysis of articles published in Infosystems International. Diabetes Res Clin Pract. 2006;74(Suppl. 2):s123–s126.
9. Department of Health, Work of the Australian Government on diabetes. Available at: www.health.gov.au. Accessed February 4, 2014.
10. Ontario Ministry of Health and Long-Term Care, Assistive devices program. Insulin pump therapy. Available at: www.health.gov.on.ca/en/public/programs/adp/insulin_pamp.aspx. Accessed April 12, 2016.
11. Pharmaceutical Management Agency, Funding of New Zealand medical and scientific insulin pump and consumables approved. Available at: www.pharmac.govt.nz/2012/08/08/2012-08-08%20Notification%20of%20Insulin%20pumps.pdf. Accessed April 12, 2016.
12. Juvenile Diabetes Research Foundation. Insulin pump grants. Available at: http://jdrf.org.au/type-1-diabetes/insulin-pmp-program-information. Accessed April 12, 2016.
13. Diabetes Australia, National Diabetes Services Scheme—product and supply. Available at: https://www.ndss.com.au/product-and-supply. Accessed August 1, 2016.
14. Grunberger G, Abelseth J, Bailey T, et al. Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump therapy task force. Endocr Pract. 2014;20(5):463–489.
15. The Australian National Adult Insulin Pump Therapy Working Group. Provision of quality care for adults with type 1 diabetes requiring insulin pump therapy (IPT). Infosyst Asia. 2013;8(1):1–12.
16. The Australian National Adult Insulin Pump Therapy Working Group. Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia. Intern Med J. 2015;45(1):86–93.
17. James S, Perry L, Gallagher R, et al. Diabetes educators' intended and reported use of common diabetes-related technologies: discrepancies and dissonance. J Diabetes Sci Technol. 2016;10(6):1277–1286.
18. Lynch P, Riedel A, Samant N, et al. Resource utilization with insulin pump therapy for type 2 diabetes mellitus. Am J Manag Care. 2010;16:892–896.
19. Wheeler B, Heels K, Donaghue K, et al. Insulin pump—associated adverse events in children and adolescents—a prospective study. Diabetes Technol Ther. 2014;16(9):1–5.
20. Diabetes Australia, Insulin pump therapy in Australia. The case for action. Diabetes Australia; Canberra: Australian Government, 2014.
21. Hunter New England Health, Our district. Available at: www.hnehealth.nsw.gov.au/Pages/Our-District.aspx. Accessed March 10, 2016.
22. Gibbs G. Analysing Qualitative Data. London: Sage Publications; 2012.
23. Perry L, Steinbeck K, Dunbabin J, et al. Lost in transition? Access to and uptake of adult health services and outcomes for young people with type 1 diabetes in regional New South Wales. Med J Aust. 2010;193(8):444–449.
24. Perry L, Lowe J, Steinbeck K, et al. Services doing the best they can: service experiences of young adults with type 1 diabetes mellitus in rural Australia. J Clin Nurs. 2012;21(13-14):1955–1963.
25. Von Sengbusch S, Müller-Godeffroy E, Häger S, et al. Mobile diabetes education and care: intervention for children and young people with type 1 diabetes in rural areas of northern Germany. Diabet Med. 2005;23:122–127.
26. Brundisini F, Giacomini M, DeJean D, et al. Chronic disease patients' experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis. Ontario Health Technology Assessment Series. 2013;13(15):1–33.
27. James S, Gallagher R, Dunbabin J, et al. Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review. BMC Res Notes. 2014;7(593):1–11.
28. James S, Perry L, Gallagher R, et al. Service usage and vascular complications in young adults with type 1 diabetes. BMC Endocr Disorders. 2014;14(39):1–9.
29. Colagiuri S, Brnabic A, Gomez M, et al. DiabCo$t Australia Type 1: Assessing The Burden of Type 1 Diabetes in Australia. Canberra: Diabetes Australia; 2009.
30. Roze S, Smith-Palmer J, Valentine W, et al. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in type 1 diabetes: a systematic review. Diabet Med. 2015;34(11):1415–1434.
31. Cheung R, Mui V. Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspective. J Diabetes Sci Technol. 2015;9(3):706–710.
32. Queensland Health. Inpatient Guidelines: Insulin Infusion Pump Management. Brisbane: Queensland Health; 2012.
33. Dunbabin J, Perry L, Steinbeck K, et al. Can Telehealth engage young people with type 1 diabetes? Experiences from the YOuR-Diabetes Project. Aust. Diabetes Educ. 2015;18(3):32–34.